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Pathogenicity of Rickettsia helvetica is relatively un-
known. We isolated a spotted fever group rickettsial organ-
ism from a patient with subacute meningitis. Nucleotide 
sequences of the 16S rRNA, ompB, and 17kDa genes 
identiﬁ  ed the isolate as R. helvetica. This organism may be 
associated with serious infections such as central nervous 
system disorders.
R
ickettsia helvetica, a member of the spotted fever group 
rickettsiae (SFGR), has been isolated from Ixodes rici-
nus ticks in many European and Asian countries. Although 
I. ricinus ticks are the main vector and natural reservoir, the 
organism has recently been found in Dermacentor reticu-
lates ticks (1–5). Serosurveys have found antibodies reac-
tive to R. helvetica in 1.9%–12.5% of the population in Lao 
People’s Democratic Republic, France, Italy, Denmark, 
and Sweden (1,4,6–8). The organism has mainly been con-
sidered nonpathogenic; several patients with a serologic 
diagnosis have had mild, self-limited disease with associ-
ated fever, headache, and myalgia. However, a more severe 
clinical disease has been demonstrated (1,9).
It is well known that Q fever and the rickettsial dis-
eases typhus and spotted fever may cause central nervous 
system infection and that, of the SFGR, R. rickettsii, R. 
conorii, and R. japonica have a documented association 
with meningitis (10,11). We document a case of subacute 
meningitis caused by R. helvetica. The study was reviewed 
and approved by the Ethics Committee, Uppsala Univer-
sity, Sweden.
The Case
In September 2006, a 56-year-old woman was hospi-
talized in Falun, Sweden, after 3 weeks of illness with grad-
ually worsening headache and fever. She had no lymphade-
nopathy, rash, eschar, or history of tick bite or tick exposure. 
Radiographs showed a small, retrocardial pulmonary inﬁ  l-
trate, but the patient had few, if any, respiratory symptoms. 
Laboratory tests showed elevated C-reactive protein (56–
128 mg/L), slightly elevated to reference-level leukocyte 
count (9,800–12,000 cells/μL), slightly low thrombocyte 
count (150,000 cells/μL), and reference values of hemo-
globin and of aspartate and alanine aminotransferases. 
Cerebrospinal ﬂ  uid (CSF) showed a slight pleocytosis (28 
cells × 108/L, of which 18 ×108/L were mononuclear cells) 
but was otherwise within reference limits. CSF was stored 
at –20°C in a regular freezer and thawed only when used 
1 year later. Negative results were obtained for blood and 
CSF cultures and for investigation for herpesviruses, tick-
borne encephalitis, and enteroviruses. Urine was negative 
for Legionella and pneumococcal antigens, and serum was 
negative for antibodies against Borrelia burgdorferi. Com-
puted tomography images of the brain and sinuses were 
unremarkable. 
Intravenous administration of cefuroxime had no effect 
on the fever. Because atypical pneumonia was suspected, 
treatment was changed after 3 days to doxycycline (100 mg 
2×/day). After 2–3 days the patient’s fever was gone, and 
she slowly recovered. The treatment was continued for 10 
days. At a follow-up visit 1 year later, the patient was still 
well but had been asthenic for several months. No antibod-
ies against Mycoplasma pneumoniae or Coxiella burnetii 
were found at the follow-up visit, and no other possible 
causative agent was conﬁ  rmed. After giving informed con-
sent, the patient was retrospectively included in an ongoing 
project that involved searching for fastidious organisms.
The patient’s previously frozen CSF was divided into 
2 aliquots; bacterial DNA was extracted by using a MagNa 
Pure Kit (Roche Diagnostics GmbH, Mannheim, Germany) 
according to the manufacturer’s instructions. A genus-spe-
ciﬁ  c real-time PCR, as described by Stenos et al. (12), was 
used to detect SFGR. The PCR was performed in a Lightcy-
cler 1.0 Real-Time PCR System (Roche Diagnostics GmbH) 
by using an LC Taqman Master Kit (Roche Diagnostics 
GmbH), primers, and TaqMan probe targeting the citrate 
synthase gene (12). To minimize risk for contamination, 
0.25  μL LC uracil-DNA glycosylase (Roche Diagnostics 
GmbH) was included in each reaction. The positive control 
contained puriﬁ  ed DNA of R. helvetica originally isolated 
from a domestic I. ricinus tick (3); the negative control con-
tained sterile water. Positive samples were further analyzed 
by using 3 nested PCRs that amplify the 17kDa, outer mem-
brane protein B (ompB), and 16S rRNA gene fragments as 
previously described (3,13,14) (Table). Ampliﬁ  cation was 
conducted in a DNA thermal cycler (Hybaid, Ashford, UK) 
and a MJ Mini Gradient Thermal Cycler (Bio-Rad, Hercu-
les, CA, USA), and expected fragment sizes were conﬁ  rmed 
by gel electrophoresis in 2% agarose. Direct cycle sequenc-
ing analysis of both strands of nested PCR products was 
performed at the Center for Genomics and Bioinformatics, 
Karolinska Institutet, Stockholm, Sweden.
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Rickettsial DNA was ampliﬁ  ed by real-time PCR from 
both CSF aliquots. Positive samples were further examined 
by using nested PCRs. The sequences obtained were 165 
(17 kDa) and 253 bp (ompB) and shared 100% similar-
ity with the corresponding gene sequences of R. helvetica 
(GenBank accession nos. EU407139, EU407140).
To isolate the pathogen, we injected CSF from the 
frozen aliquot in volumes of 10 μL in a 25-cm3 ﬂ  ask into 
conﬂ  uent monolayers of Vero cells and 80 μL in the other 
(15). After incubation, the cell culture was maintained in 
Dulbecco modiﬁ  ed Eagle medium containing 10% fetal 
calf serum and kept in a humid cell chamber in 5% CO2, 
at 32°C, to allow rickettsiae to multiply. All cell lines and 
reagents were checked weekly for growth or bacterial con-
tamination. Detection of growing rickettsiae was monitored 
by using Gimenez staining and an immunoﬂ  uorescence as-
say of cells collected after centrifuging the medium and 
staining with rabbit antirickettsial hyperimmunserum and 
Alexa Fluor 488 goat antirabbit immunoglobulin (Ig) G 
(H+L) conjugate (Invitrogen, Carlsbad, CA, USA) as sec-
ondary antibody (Figure). 
After 6 weeks, many intracellular bacteria were ob-
served in the cells. Rickettsial DNA was veriﬁ  ed by real-
time PCR (12). The sequences obtained by nested PCR for 
the 17kDa and ompB genes in the isolate grown in Vero 
cells were identical to the sequences of the isolates obtained 
from the CSF (3,13,14). Ampliﬁ  cation and partial sequenc-
ing of the 16S ribosomal RNA gene of the isolate produced 
fragments of 1,400 and 750 bp, respectively, which were 
100% homologous to fragments of the deposited 16S ribo-
somal DNA sequence of R. helvetica from ticks (GenBank 
accession no. L36212).
SFGR antigen prepared from isolates grown in Vero 
cells of R. helvetica from an I. ricinus tick and from the 
patient was applied to each well of microscope slides. The 
antigen was dried, ﬁ  xed in acetone, and incubated with se-
rial dilutions of serum or CSF, as previously described (7). 
The positive control was serum from a patient with proven 
Mediterranean spotted fever and end-point IgG titers of 
160 (provided by the Swedish Institute for Infectious Dis-
ease Control); the negative control was phosphate-buffered 
saline and serum from 3 healthy blood donors. IgG was de-
tected by ﬂ  uorescein isothiocyanate–conjugated γ-chain–
speciﬁ  c polyclonal rabbit antihuman IgG (DakoCytoma-
tion A/S, Glostrup, Denmark). Microimmunoﬂ  uorescence 
assay showed IgG end titers of 160 and 320 in the early-
phase serum sample when the isolates of R. helvetica from 
tick and patient, respectively, were used as antigens. No 
antirickettsial IgG was detected in CSF when either isolate 
was used as antigen.
Conclusions
For patients with fever and headache but no rash or 
eschar, diagnosis is difﬁ  cult and can probably not be based 
only on epidemiologic, clinical, and standard laboratory 
criteria. It therefore seems that in SFGR-endemic areas, 
SFGR should routinely be included in the differential di-
agnosis of cause of meningitis. Appropriate antimicrobial 
drug therapy is essential for prompt recovery and preven-
tion of complications.
SFGR isolation is usually not available in ordinary 
hospital laboratories and is too time-consuming to be a di-
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Table. Selected inner primers and probe used to amplify genes from cerebrospinal fluid of patient with subacute meningitis, Sweden, 
2006* 
Gene  Primers and probe  Nucleotide sequences, 5ƍ ĺ 3ƍ  Product size, bp 
ompB  ompB-IF CCAATGGCAGGACTTAGCTACT  267 
ompB-IR AGGCTGGCTGATACACGGAGTAA   
17 kDa  RH 17-IF  GCATTACTTGGTTCTCAATTGG  214 
 RH  17-IR  AACCGTAATTGCCGTTATCCGG   
16SrDNA Ric-F  TCTAGAACGAACGCTATCGGTAT  757 
 Ric-R  TTTCATCGTTTAACGGCGTGGACT   
gltA SFG-CS-F  TGCCAAATGTTCACGGTACTTT  74 
 SFG-CS-R  CACAATGGAAAGAAATGCACGA   
 SFG-CS-Probe  TGCAATAGCAAGAACCGTAGGCTGGATG   
*ompB, outer membrane protein B; gtlA, citrate synthase. 
Figure. Rickettsiae in infected Vero cells. Sample from cerebrospinal 
ﬂ  uid of patient with subacute meningitis, Sweden, 2006. Gimenez 
stain; original magniﬁ  cation ×1,000.agnostic alternative in clinical settings. Although this pa-
tient’s CSF had been stored in a regular freezer for 1 year, 
the rickettsial organisms were still viable.
PCR seems to be the most practical way to diagnose a 
suspected central nervous system disorder such as meningi-
tis. The ampliﬁ  ed nucleotide sequences were long enough 
to exclude other related rickettsial species. For example, 
the differences from other related rickettsiae were 10 and 5 
nt for the R. monacensis 17kDa and ompB gene fragments, 
respectively, and 8 nt for R. slovaca ompB. Our study sug-
gests that R. helvetica may cause infection of the CNS. 
When seeking to diagnose possible agents of meningitis, 
the usefulness of PCR and the relevance of the broader 
clinical spectrum of acute febrile illness caused by R. hel-
vetica should be considered. 
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